The top barriers to changing or improving practice identified by 2017 learners were multidisciplinary communication and understanding of all treatment options.The 2019 multidisciplinary planning committees reviewed these barriers and noted that regarding treatment of patients with thoracic malign

Difficult or controversial clinical cases are presented along with several different management plans favored by select specialists in that field, who provide thought-provoking viewpoints.

Contouring Covered:

The 2020 Best of ASTRO meeting provided a review of the most relevant, highly-rated abstracts from the 2020 Annual Meeting that highlight recent technological advances and illustrate the importance of the clinical and non-clinical skills needed to provide patients with the full benefit of radiati

The 2020 Best of ASTRO meeting provided a review of the most relevant, highly-rated abstracts from the 2020 Annual Meeting that highlight recent technological advances and illustrate the importance of the clinical and non-clinical skills needed to provide patients with the full benefit of radiati

IJROBP Journal SA-CME activity for December 1, 2020 provides practitioners some practical knowledge needed to counsel patients in the setting of various treatment regimens in the management of localized prostate carcinoma.

There is significant interest in the potential of combining immunooncology drugs (IO) with radiotherapy (RT).

This activity will discuss current clinical scenarios in prostate cancer with an expert panel discussing decision points starting from a patient case but expanding to include audience responses, the panel's opinion, and finally discussing the evidence and guidelines for each situation.

IJROBP Journal SA-CME activity for October 1, 2020 provides practitioners with information regarding the combination of radiotherapy and modern checkpoint inhibition immunotherapy.